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SERS based immunoassays for point-of-care diagnostics is a promising tool to facilitate 
biomarker detection for early disease diagnosis and control. The technique is based on a 
sandwiched system in which antigen is first captured by a selective substrate and then labeled by 
an extrinsic Raman label (ERL). Here, we report on the use of gold nanoparticle modified filter 
paper as a novel capture membrane in a vertical flow format. This vertical flow configuration 
affords reproducible flow of sample and label through the capture substrate to overcome 
diffusion limited kinetics and significantly reduced assay time. The filter paper was selected due 
to its affordability and availability, while the embedded AuNPs maximized plasmonic coupling 
and SERS enhancement. Additionally, the embedded AuNP served as a scaffold to immobilize 
capture antibody to specifically bind antigen. In this work, a SERS-based rapid vertical flow 
(SERS-RVF) immunoassay for detection of mouse IgG was developed to establish proof of 
principle. Optimization of assay conditions led to a limit of detection of 3 ng/mL, which is 
comparable to more traditional formats carried out in multi-well plates and significantly reduced 
assay time to less than 2 minutes. Additionally, IgG was accurately quantified in normal serum 
to validate the SERS-RVF assay for application to the analysis of biological samples. These 
results highlight the potential advantages of the SERS-RVF platform for point-of-need testing. 
KEYWORDS: Immunoassay; surface-enhanced Raman scattering (SERS); plasmonic paper; 
vertical flow assay; point-of-need (PON) testing; point-of-care (POC) diagnostics 
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CHAPTER I: INTRODUCTION 
 
Significance of Study 
 
The health and well-being of a nation’s labor force determine the long-term social and 
economic stability of that nation. The world health and technology has seen many improvements 
the last 50 years [1]. However, there is still more to do as millions die each year in populated 
countries due to infectious diseases like malaria, AIDS and tuberculosis. These deaths are 
sometimes due to the challenge of easy treatment options such as in developed countries. Ability 
to precisely diagnose diseases at their onset of development is a key to determining the origin of 
the disease. Research proves that the inability to rapidly diagnose diseases which are treatable 
and preventable at their early stage accounts for the progressive increase in the number of deaths 
especially in the low- and middle-income countries [1, 2]. 
Recent improvement in the disease diagnosis has been focusing on early detection of 
disease to efficiently provide good medication in order to control the passing pace of patients. 
For some time now, many healthcare practitioners have been relying on sophisticated laboratory- 
based procedures to diagnose disease which has the limitation of long analysis time and requires 
expertise to generate results. The current advancement and development in the disease diagnosis 
has been focusing on point-of-care testing (POCT). POCT is the integral part of medicine, it 
enables simple automated testing that yield fast results. 
 
 
Point-of-Care Testing 
 
POCT refers to diagnostic test that is performed in proximity of patients where medical 
attention is needed to diagnose, monitor and control disease [3, 4]. The test is typically 
performed by doctors, laboratory personal or patients. Samples such as blood are collected from 
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the patients and analyzed. POCT devices offer advantage of rapid diagnosis of the disease, 
minimal sample volume for testing portability and cost effectiveness. POCT are normally used in 
hospitals, paramedic support vehicles and many other environments [5]. The ability of a POCT 
device to selectively extract and detect the disease biomarker from the patient sample’s matrix 
such as the serum, blood and urine and provide results within a short time makes it an attractive 
in the diagnostic arena. The demand for POCT devices has been increasing due to the 
corresponding global increase of chronic and infectious diseases. 
Currently, there have been huge investments in the field resulting in a high value of the 
global POCT market [6], which was estimated at $13.87 billion in 2017 and is estimated to grow 
over $23.92 billion by 2026 [7]. Recently, there have been enormous research publications 
aiming to improve the current POCT. The majority of these publications have been focused on 
increasing sensitivity, affordability and simplicity of the device. The most common POCT 
platforms are based on lab-on-a-chip [8], paper [9], microfluidics [10] and novel assay formats 
[11, 12]. 
 
 
Immunoassay and its Application 
 
The advancement in complementary technologies and the continuous improvements play 
a vital role in development of next-generation POCT technologies. One key area that is gaining 
much attention for development of point-of-care testing is the immunoassay, which has been 
extensively utilized from basic research science to clinical settings, due primarily to the 
specificity of antibodies for their molecular antigen counterparts. 
Immunoassay refers to a test in which responses are based on the interactions between 
antibody and antigen (analyte) and are commonly relied on for the diagnosis of many infectious 
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diseases [13, 14]. The technique was developed by Rosalyn Sussman Yallow in 1950 which 
resulted in the Nobel Prize in 1977 [15]. The technique offers several advantages such as 
inexpensive testing, high sensitivity, high selectivity and can be applied to various targets. The 
most common applications include drug testing [16], hormone testing [17, 18], bacterial or viral 
testing [19, 20] and environmental testing [21, 22]. 
The main principle of immunoassays is based on the ability of the antibody to recognize 
and bind to specific antigen to form an antibody-antigen complex also refers to as an 
immunocomplex. This complex formation is then separated from the unbound antigens through a 
series of washing steps and are detected by measuring the activity of a label that is covalently 
link to either antibody or antigen depending on the interest of the assay. Immunoassays have 
been used in various applications and there have been many research publications to improve the 
field [20, 21, 23, 24]. 
 
 
Formats of Immunoassay 
 
Immunoassays come in two main forms: heterogeneous and homogeneous. In the case of 
heterogeneous, either the antibody or antigen is immobilized on a solid support (for example test 
tubes, microplates, latex beads, filter paper or magnetic particles) followed by washing to 
remove any unbound material [15]. The heterogeneous immunoassay comes in competitive and 
noncompetitive formats, the noncompetitive format is displayed in Figure 1a [25]. Here, the 
antigen sample is incubated with an excess of antibody reagent. All the antigen molecules 
become bound, but not all the antibody binding sites are occupied. To detect the amount of 
antigen attached to an antibody, a second, labelled antibody is added which binds to another 
epitope of the antigen. This leads to formation of a sandwich-complex between the primary 
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antibody, the sample antigen and the labelled secondary antibody. After washing off any excess 
reagent, the sandwich-complexes containing the label can be detected and the signal generated is 
directly related to the amount of antigen in the sample. The response of this type of format is 
displayed in Figure 1b [25]. The labelled secondary antibody binds directly to the target antigen- 
antibody complex. So, the larger the number of sample molecules, the larger the signal, but with 
very high or low concentration the curve flattens out [30]. Heterogeneous immunoassays are 
used in most environmental and clinical applications as a result of the complex samples typically 
encountered. A good example of application of this format is HIV-antibody detection [26, 27] . 
In a homogeneous immunoassay format, there are no separation steps of the 
immunoreagents which sometimes results in matrix interferences. 
 
 
(a) 
Antigen Binding 
Immobilized Antibody 
5  
 
 
 
 
Figure 1. Immunoassay formats (a) Non-competitive (b) Response of non-competitive 
  
Antibodies and its Structural Activities 
 
Antibodies, also referred to as immunoglobins, are proteins that are essential in the 
immune system. They recognize and neutralizes pathogens or antigens (Ag) (proteins, 
polysaccharides, nucleic acids) that invade the body and stimulate the production of 
immunoglobins. Antibodies have been used in various biosensor platforms including 
electrochemical [28], fluorescent [29] and colorimetric assays [30]. There are two main types of 
antibodies that are used in immunoassay, monoclonal or polyclonal. Monoclonal antibodies bind 
only one single binding site (epitope) on the antigen, while the polyclonal antibodies are able to 
bind to different sites (epitopes) of the same antigen. The use of monoclonal antibodies has the 
Non competitive assay response 
Signal 
Intensity 
(b) 
Change of Concentration 
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advantage of less cross-reactivity due to its specificity to one binding site than the polyclonal, 
however, many biosensors make use of polyclonal due to its low cost of production. 
Immunoglobin G (IgG) has a general structure which consists of a distinctive Y-shape 
and are composed of two heavy chains and two light chains as shown in the Figure 2. These 
chains are held together by disulfide bonds. The regions that bind to pathogens are located at the 
tips of the two arms formed by heavy and light chain domain called hypervariable region. The 
hypervariable region also referred to as Fab or paratope ends with the NH3+ terminal of amino 
acid that binds to the epitope (binding site of antigens). The Fab of each antibody is unique and 
allows the antibody to interact with a specific antigen. The antibody and antigen interact in a 
lock and key manner. This unique feature of the antibody explains the selectivity and specificity 
of immunoassays and their value for the detection of diseases. There are five types of antibodies 
found in human and other mammals. Thus IgG, IgM, IgA, IgD and IgE, the most abundant one is 
the IgG. The IgG types have a molecular weight of approximately 150 kDa. Each type has 
different shape and size. 
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Figure 2. Structure of immunoglobin G (IgG). Red variable region of light and heavy chain for 
antigen binding site and grey constant region that has heavy and light chain. 
 
 
Established Immunoassay Formats 
 
The complex formation of the immunochemical reaction between the antibody and 
antigen serve as the basis of the immunoassay. They may be visualized or detected by measuring 
the activities of the label used. The type of label will determine the format of the immunoassay 
assay and the method of detection. Several prominent assay formats have been developed during 
the last two decades for highly prospective POCT. A recent review has provided a summary of 
the various detection methods with different advantages and limitations [31]. Labels and 
detection techniques such as fluorescence polarization [32], chemiluminescence [33], 
electrochemical detection [34] and surface enhanced Raman spectroscopy (SERS) [35], as well 
as more novel labels, have also been explored to enhance the detection of trace analytes [36]. 
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The current method of detection that is employed as standard diagnostic platforms are 
the enzyme-linked immunosorbent assay (ELISA) [26, 30, 37] and the lateral flow assay (LFA) 
[38, 39]. ELISA uses enzyme labels such as alkaline phosphatase and horseradish peroxidase on 
the secondary antibody providing a colored end product. In one form of ELISA, sample 
containing the antigen is added to a well plate which is coated with the antigen-specific antibody 
and then incubated for several hours. After incubation a series of washing is done to remove 
excess unbound antigens, then an enzyme label antibody is added followed by the addition of 
substrate which results in the formation of a colored product. The quantity of the antigen present 
is quantified by measuring the absorbance of the colored product. Figure 3 illustrates the ELISA 
process. ELISA offers quantitative information but it is a time-consuming multistep process [40]. 
LFA has also been used as an alternative to reduce turnaround time by providing rapid 
results for several analyses [41]. LFA makes use of a nitrocellulose membrane test strip which 
allows samples to flow laterally through the strip by the action of capillary force provided by 
absorbent pads. Here the sample is applied on a sample pad and begins to flow laterally over the 
conjugate pad where the analyte binds with the conjugate’s particles. Figure 4 details the process 
of LFA [38]. LFA is rapid and simple technique which is used as a point-of-care diagnostic by 
healthcare professionals, patients and individuals. LFA has been extensively utilized for various 
analysis, for example, the most widely used pregnancy tests are based on the LFA principle 
where the human hormone chorionic gonadotropin (hCG) in urine is detected [42]. LFAs have 
also been develop for the detection of cancer biomarkers [43], HIV diagnosis [44, 45] and 
nucleic acid testing [46, 47]. Despite the importance of this platform, it also comes with several 
limitations including poor limit of detection [48]. According to reports from Hurt et al [49], LFA 
was used in population screening of people infected with influenza virus using the commercially 
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available products Binax Now Flu A&B, BD Directigen EZ Flu A+B, Rockedby influenza A and 
Quidel Quickvalue Flu A+B. The LFAs only identified 73%, 69%, 10% and 67% respectively of 
the know positive cases [49]. Recently, rapid vertical flow (RVF) assays have been explored as 
an alternative to LFAs in an effort to reduce the false negative rates and provide even faster 
analysis [50, 51]. 
Given these limitations, there has been several reports on ways to improve the uses of 
these conventional flow assay platforms, with majority of them focusing on enhancing the 
sensitivity using novel detection modalities such as surface plasmon resonance (SPR) [52], 
nanowires [53], and quantum dots [54]. However, each of these improvements sacrifices the 
simplicity, precision and low cost of POCT. An alternative to these detection modalities is 
SERS. The exceptional properties of SERS such as high sensitivity, potential for multiplexed 
detection, photostability, and portability allows it to be more useful than other techniques in the 
diagnostic arena especially with the recent development of portable hand-held Raman 
spectrometers [55]. 
   
Coated antibody Sample incubation and 
antigen binding 
Labelled antibody binds 
with captures antigen 
Addition of enzyme which 
is converted into colored 
product 
 
Figure 3. Principle of enzyme linked immunosorbent assay. 
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(b) 
 
 
 
 
 
(c) 
 
 
Figure 4. Principle of lateral flow assay. (a) sample is applied to sample pad (b) sample bind 
with conjugates and flow across by capillary force (c) conjugates are bind to immobilized 
antibody at the test line to form a color and the control line indicates that. 
 
 
Surface Enhanced Raman Spectroscopy (SERS) 
 
Raman spectroscopy is a vibrational spectroscopy resulting from inelastic scattering of a 
monochromatic light (e.g laser) by atoms of a molecule. Raman spectroscopy is widely used for 
the analysis of biological materials such as proteins [56], DNA [57] and chromosomes [58]. The 
molecular composition and the extent of atomic interactions contribute to the vibrational 
spectrum of the molecule, which provides valuable information for identification and 
quantification of the molecule. However, a large concentration of the analyte molecule is 
required to enable the Raman spectroscopic analysis. This has been a major disadvantage to the 
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use of Raman spectroscopy for the analysis of biological compounds which are present in small 
quantities resulting in the generation of weak signal from the spectrum. Moreover, a high laser 
power of about 300 mW is required which can cause damage to biological samples. 
The limitation of Raman spectroscopy has been overcome through SERS. SERS is 
defined as an analytical technique that is used to obtain the vibrational spectrum of molecules 
adsorbed onto metallic nanostructures which provides large SERS active surface area for signal 
enhancement. SERS has become more useful and has been found in many applications [59] due 
to its ability to enhance the Raman signal by a factor of 1010 [60]. The SERS phenomenon is a 
result of the energy changes of the light scattered by vibrating molecules adsorbed on a metallic 
surface [61]. The factors contributing to SERS enhancement have been found to be chemical and 
electromagnetic in nature [62]. 
The electromagnetic (EM) effect has been found to be the strongest contribution to the 
SERS enhancement due to the strong vibration of the molecules experienced at the surface of the 
metal particle. In the EM phenomenon, the electromagnetic wave of an incident laser impinges at 
the metal and dielectric interfaces which energizes the delocalized conduction electrons of the 
metal nanostructures into collective oscillation (Figure 5). When the frequency of the incident 
light matches with the inherent oscillation frequency of free electrons in the metal, SPR occurs. 
The magnitude of the SPR generated depends on the size, shape, electron density and dielectric 
environment of the nanostructure [63]. The SPR that is generated is highly localized on the 
metallic surface and is referred to as localized surface plasmon resonance (LSPR) and the 
metallic substance is termed as plasmonic nanoparticle (PNP). During the enhancement process, 
the LSPR generated at the surface of the PNP couples with the incident light’s resonance which 
result to huge signal generation [63]. The magnitude of this enhancement has been determined to 
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reach from 103 to 1010 [26]. This phenomenon has led to significant effort to improve the 
analytical performance of SERS techniques. Today many articles [64, 65] and reviews [66, 67] 
have been published, all aiming at controlling the size, structures and distance of the PNP to 
provide reproducible fabrications of optimal conditions for highly sensitive analytical analysis. 
The most common metals found to observe this phenomenon are gold and silver. Gold 
has been preferred over silver in the analysis of biological compounds due to its longer excitation 
wavelength (above 600 nm) and excellent biocompatibility [67]. 
 
 
 
E-field 
 
Figure 5. Electromagnetic effect of SERS. Incident light set the electron clouds into oscillation 
to generate large local field, two NP at a closed proximity increased in oscillation due to 
coupling of local electric field which enhanced signal. 
 
 
SERS Hot Spots 
 
Development of SERS technology to detect single molecules has been reported in several 
papers [68, 69] and it has been found that aggregated nanoparticles produce higher enhancement 
Incident light 
E-field 
Electron cloud 
Au Au 
Electron cloud 
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than a single plasmonic nanoparticle [70, 71]. The enhancement contribution of the aggregated 
nanoparticle has been attributed to the interparticle distance between two PNP that are brought to 
closed proximity to each other. The space that is created by the two nanoparticles generates a 
very high electric field (as shown by Figure 5) as a result of the interaction of the electron clouds 
surrounding the particles and therefore produced an extremely strong SERS signal. The volume 
of the space that creates this strong SERS signal is referred to as a SERS-hot spot [72, 73]. These 
advantages have enabled various applications of SERS such as noninvasive chemical detection 
and identification of biological molecules such as proteins [74] and DNAs [75]. 
 
 
Figure 6. Illustration of SERS-hot spot (red). Generated due to decrease in interparticle distance. 
 
 
SERS-Based Immunoassay 
 
Recent developments of SERS-based immunoassays have been focused on increasing the 
sensitivity of the SERS substrate for various applications [76, 77]. One area that has been 
intriguingly successful and gaining much attention is PNP-enabled SERS immunoassay [76, 78]. 
The SERS active surface is fabricated by carefully arranging a gold nanoparticle array which 
generates the localized surface plasmon resonances and the laser exposure to the analytic 
biomolecules. The main focus of the SERS technology is to control the interparticle gap and 
Au Au 
Au 
14  
diameter of the metal nanoparticles in order to generate SERS hot spots which increase the SERS 
signal when analytic biomolecules are close to the SERS-active surface. 
A recent report indicates that SERS hot spots can be generated when the interparticle 
distance is less than 10 nm [79]. The detection of biomolecules using gold nanoparticle SERS 
strategy has been used in various applications. For example, Wang et al. reported the use of 
Raman label bound to an antibody-functionalized gold nanoparticle to indirectly detect rabbit 
IgG [35]. Also, there have been SERS immunoassay reports on the quantitation of HIV-1 [45] 
and staphylococcal enterotoxin [80]. 
Current developments in SERS-based immunoassays are focused on coupling SERS with 
POCT immunoassay platforms. For example, Clark et. al reported on coupling SERS with RVF 
for the detection of hepatitis C (HCV) biomarker using a nitrocellulose membrane as the capture 
substrate [51], however their technique suffers from limited sensitivity because of non-coupling 
of gold nanoparticles. 
There have been several reports describing the plasmonic coupling in interacting AuNPs 
and has been found that the enhancement generated from the nanoparticle gap increased as the 
gap between the interacting nanoparticles decreases [81, 82]. Also, Wulstholz et al [97] reported 
that the enhancement is independent of the cluster size and excitation wavelength and that SERS 
enhancement increases with decreasing interparticle distance. Guerrini et al. also reported 
through the use of DNA triplexes to control the interparticle distance in nanoparticle clusters in 
suspension and found that the SERS enhancement correlated with nanoparticle gap distance 
rather than cluster or plasmon band [83]. There are several other publications which support the 
development of SERS as a quantitative analysis technique based on aggregation assays [84]. 
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Thus, a SERS-based immunoassay that capitalizes on these nanoparticle-nanoparticle 
interactions would offer substantially improved sensitivity. 
The SERS-based immunoassay consists of three main parts, the capture substrate, the 
analyte (antigen to be detected) and a functionalized gold nanoparticle. The capture substrate 
consists of a primary antibody immobilized on the surface of a support which selectively 
captures the specific antigen from the sample solution. The analyte is the antigen within the 
sample solution which is under investigation; they are usually macromolecules such as DNA or 
protein. The third component is composed of a gold nanoparticle which has a secondary antibody 
immobilized on its surface and is functionalized with a Raman reporter molecule in a system 
called the extrinsic Raman-label (ERL). 
The ERL is an essential part of the assay which is normally used as a tracer molecule in 
the SERS-based assay to identify the presence of the analytes. The characteristic of the Raman 
spectrum produced is determined by the Raman reporter molecule which is used to identify the 
analytes. The narrow spectral width of the vibrational Raman band enables all SERS labels to be 
simultaneously excited with a single laser which gives advantage for SERS to identify many 
particles simultaneously. Examples of Raman labels used in SERS-immunoassays are 4- 
nitrobenzenethiol (NBT) and para-aminothiophenol (p-ATP) [85]. 
There have been extensive on reports nanoparticle (NP) enabled SERS immunoassays for 
bioanalytical applications, and they have been used for diagnostic applications [86]. The first 
SERS-based immunoassay was developed by Ni et al. in 1999. Here, a glass slide was coated 
with gold film and the antibody immobilized on it, analyte is then incubated with the antibody 
and washed off excess reagents followed by adding the ERL and then washed again to remove 
nonspecific binding. The sandwiched formation is then detected using SERS. The procedure is 
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simple and sensitive but has long preparation time due to slow movement of large mass of 
analytes (antigen) to bind with the antibody during incubation process, which can take overnight. 
The ideal SERS-based immunoassay for point-of-care testing should be rapid, sensitive, 
easy-of-use and affordable. The speed of immunoassay plays a vital role in the diagnostic arena 
especially in a point-of-care testing. At the intensive care unit (ICU), POCT is used to diagnose 
patients with various life-threatening conditions, and the faster the diagnosis the sooner the right 
medical treatment response. Recent advancement in the field has been showing significant effort 
to speed up the SERS-based immunoassay through various ways. Our group previously 
developed a system using a syringe to facilitate the diffusional mass transport of analytes [87]. 
However, this technique also suffers from imprecision because of variable flow rate. A vertical 
flow system which is fast and ensures a consistent flow of solution was reported by Clarke et al, 
however, the technique is not sensitive due to non-coupling of nanoparticles [51]. 
An assay format that is highly sensitive to diagnosis trace amounts of analytes is on high 
demand. Recent developments towards increasing sensitivity of SERS-based assays has been 
focusing on improving the nanoparticle that are used as SERS-substrate [88]. 
 
 
SERS Substrates 
 
SERS is a technique that involves the emission of radiation as a result of inelastic 
scattering of incidence laser energy that impinges on the surface of a nanometallic object which 
results in spectral peaks due to the vibrational modes of the molecule that are frequency shifted 
from the incident energy. 
SERS substrate is the metallic object on which the analyte molecule is adsorbed and 
detected. Almost all polyatomic species exhibit Raman or SERS spectral emission. A typical 
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example of SERS substrates are roughened silver, copper and gold surfaces. These SERS 
substrates were in the form of colloids and foils/wires, however, recent development in the SERS 
substrate reveal three main classifications, nanoparticle suspension, immobilized nanoparticle on 
solid support and fabricated nanoparticle on substrates by special treatment such as lithography 
synthesis. Several papers have demonstrated the use of these substrates for various applications. 
Our focus is on the immobilization of metallic nanoparticles on a solid support and more 
emphasis will be laid on immobilization on filter paper. Aggregation of spherical particle on a 
solid support ensures maximum SERS enhancement [14] due to formation of SERS-hot spots. 
Immobilization of the nanoparticles on a solid support provides a means of this aggregation. 
Several immobilization strategies have been used to chemisorb nanoparticles on a solid support. 
Recently, immobilization of substrates on paper methods have gained attention due to the high 
flexibility, biocompatibility, biodegradability and low cost [50], and many papers have been 
reported [50, 89]. For example, Fierro-Mercado et al, reported on a highly sensitive filter paper 
substrate for SERS trace explosives detection [90]. In that work a thermal inkjet printer was used 
to print colloidal nanoparticles onto filter paper. 
The SERS signal enhancement is achieved by controlling the plasmonic properties and 
morphology of the nanostructures that are used as SERS substrates. As such, significant efforts 
are underway toward an architectural modification of the plasmonic particles with new methods 
of fabrications to enhance SERS signal. This process is tedious and requires many steps and 
therefore is time consuming that limits SERS application as a fast and cheap technique. 
Therefore, the need to develop a rapid, sensitive and easy-to-use platform to detect biomarkers is 
required to advance disease diagnostic arena for the management of disease. 
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Paper-Based Assay (PBA) 
 
The use of paper-based material as SERS substrates has gained much attraction toward 
development of immunoassay due to the high flexibility, biocompatibility and cost effectiveness. 
As such, three formats have been developed including LFA, dipstick assays, and microfluidic 
paper based analytical devices (μPADs) [91]. 
The most common substrates that are used for the PBA are nitrocellulose membrane, 
filter paper, chromatography paper, and or paper/nanomaterial composites [92]. The optical 
properties and surface chemistry, as well as the porosity of these paper-based assays are very 
essential in diagnostic application. Among these papers, the most widely used is nitrocellulose 
membranes due to its broad distribution of pore sizes (0.05–12 μm) [8] for many proteins and 
DNA applications. However, they have some limitation such as large accumulation of charges 
under low humidity [93] which prevents its ease of use. The current limitation of the PBA needs 
to be critically improved by signal enhancement strategies [94] as it is inappropriate for 
diagnostic applications. Toward this end, the need of new methods to evade nonuniformity, poor 
reproducibility and variable accuracy of PBA is required. 
 
 
Thesis Objectives 
 
The goal of this research is to develop a highly sensitive point-of-care system that is fast, 
cheap and easy to use by anyone. Here we develop a new strategy through direct addition of 
second gold nanoparticle layer on the plasmonic paper to create a new sensing environment that 
would be able to enhance the SERS signal. The procedure has the advantage of simplifying the 
assay procedure to less than 2 minutes and improves sensitivity of the assay by an order of 
magnitude. This process overcomes the limitations of LFA. 
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The system consists of an antibody-gold nanoparticle conjugate functionalized with a 
Raman reporter molecule which is used to form a second layer on a modified antibody-AuNP 
plasmonic filter paper after capturing antigen from a sample that vertically flows through the 
plasmonic antibody-capture filter paper (Figure 7). The Raman reporter molecules provide a 
vibrational spectrum that indicates the presence of antigen in the sample solution. They are 
strategically designed to chemisorb as a thiolate adlayer on the gold nanoparticle, to provide a 
strong and unique spectral signature, and to covalently link a layer of the antibody to the gold 
nanoparticle. The vibrational spectrum resulting from the Raman reporter molecule is used to 
trace and quantify any captured antigen from the flow through sample. 
 
 
Figure 7. Overview of SERS VFA. Sample is applied and antigen is captured, ERL is applied to 
labelled captured antigen then analyzed with SERS. 
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CHAPTER II: MATERIALS AND METHODS 
 
All materials, reagents and various analytical procedures for this research have been 
explained in this chapter including various synthesis and physical measurements such as: 
synthesis of gold nanoparticles for fabrication of plasmonic paper, preparation of the AuNP- 
antibody conjugates and all analytical instruments used. 
 
 
Materials and Reagents 
 
Gold nanoparticles (AuNPs; 60 nm) were purchased from Ted Pella Inc. and used to 
synthesis extrinsic Raman labels (ERLs). Bovine serum albumin (BSA), 4-nitrobenzenethiol (4- 
NBT), Tween 20, and mouse IgG (I5381) were purchased from Sigma-Aldrich. Goat anti-mouse 
IgG polyclonal antibody (ab 7063) was obtained from Abcam. Normal mouse serum was 
acquired from Santa Cruz Biotechnology. Phosphate buffered saline (PBS; 10 mM, pH 7.4) and 
sodium borate buffer (50 mM, pH 8.5) were purchased from Thermo Scientific. Whatman filter 
paper grades 4 and 40 were used to prepare SERS substrate. A vertical flow device (Zoom Blot 
Plate) and high capacity absorbing pads were purchased from Vitrozm. 
 
 
Synthesis of Gold Nanoparticles (AuNPs) 
 
AuNPs were synthesized and subsequently used to prepare plasmonic paper. Briefly, AuNPs 
with □60 nm diameters were synthesized by the modified thermal reduction method [95, 96]. An 
aliquot (2.0 mL) of gold solution (1 wt% HAuCl4·3H2O) was diluted to 100 mL with water in a 250 
mL Erlenmeyer flask containing a magnetic stirring bar. After vigorously stirring the solution for 15 
min, the flask was heated to boiling. Trisodium citrate (1 wt%; 1.5 mL) was quickly added to the 
boiling solution, which led to the formation of spherical AuNPs. After completing the reaction, the 
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final solution was adjusted to 80 mL in total volume (exhibiting an extinction maximum of □2.4) and 
stored at room temperature without further purification prior to use. 
 
 
Preparation of Plasmonic Paper Capture Substrate 
 
Whatman grade 4 and 40 filter paper with 8 and 25 µm pores sizes, respectively, were 
selected to prepare the plasmonic paper capture substrate. Prepared AuNPs were embedded in 
the two filter papers using a previously developed dipping method [97-100]. The papers were 
first dried at 50 °C in an oven overnight and then immersed in 10 mL of the synthesized AuNP 
suspension in a plastic petri dishes (60 mm x 15 mm). After soaking for 24 h, the filter papers 
were removed from the AuNP suspension and completely dried in the oven (~40 °C) for 1 hr. 
The resulting plasmonic paper was then cut into circles with a 3 mm diameter for use in the 
SERS immunoassay. Unless noted otherwise, 2 µL of 1 mg/mL goat anti-mouse antibody was 
applied to the 3 mm plasmonic paper substrate and dried in a desiccator for 1.5 h before use 
[101]. 
Preparation of Extrinsic Raman Labels (ERLs) 
 
Antibody and a Raman reporter molecule were co-adsorbed onto AuNPs to prepare 
extrinsic Raman labels (ERLs), following a previously reported procedure [102, 103]. A 1.0 mL 
aliquot of 60 nm AuNPs (Ted Pella, Inc.) was added to a microcentrifuge tube and 40 µL of 50 
mM borate buffer (pH 8.5) was introduced to adjust the pH. Goat anti-mouse IgG antibody (30 
µg) and 10 µL of 1 mM 4-NBT were added and incubated for 1 hour to allow the antibody and 
4-NBT to adsorb onto the AuNPs, forming the ERLs. The ERL suspension was centrifuged at 
5000g for 5 min and the supernatant above the pelleted ERLs was discarded to remove excess 
antibody and 4-NBT that was not adsorbed to the AuNPs. The ERLs were resuspended in 2 mM 
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borate buffer and the centrifugation/resuspension cycle was repeated two additional times. To the 
purified ERLs, 10 µL of 10% BSA was added to further passivate any remaining surface on the 
AuNPs and 10 µL of 10% NaCl was added to mimic physiological ionic strength and prevent 
protein unfolding. 
Vertical Flow Immunoassay Protocol 
 
Calibration standards of the antigen were prepared by diluting a 1 mg/mL stock solution 
of mouse IgG to final concentrations of 0.1, 0.5, 1, 10, 50, 100, 200, 300 and 400 ng/mL. Two 
sets of calibration standards were prepared, one using PBS as the diluent and another using rabbit 
serum as the diluent. PBS or rabbit serum served as the negative control to assess nonspecific 
binding and specificity. The capture substrate, comprised of the plasmonic filter paper with pre- 
adsorbed goat anti-mouse IgG antibody, was then loaded on the adsorbing pad and inserted into a 
vertical flow device. Once assembled, 1% BSA (100 μL) was added to the sample well, and 
rapidly passed through the capture substrate into the absorbing pad to block the capture substrate 
and sample well surface in an effort to prevent nonspecific binding. The sample solution, e.g., 
calibration standard or normal mouse serum, was then added to the sample well and antigen 
molecules were captured on the plasmonic paper by the immobilized antibody as the solution 
freely passed through the capture substrate. Next, ERLs were added to the sample well and 
passed through the capture substrate to label any captured antigen, with excess ERLs drawn into 
the absorbing pad. Excess ERLs were removed from the surface of the plasmonic paper by 
passing a PBS rinse solution containing 5% Tween 20 through the paper. The plasmonic paper 
was removed and allowed to dry in a desiccator before SERS analysis. 
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Characterization Methods 
 
The following sections provide details of characterization techniques and the detail of 
procedures that were used to evaluate the performance of the assays, these include: Scanning 
electron microscope (SEM), Surface enhanced Raman spectroscopy (SERS), Dynamic light 
scattering (DLS) and Ultraviolet-visible spectroscopy. 
 
 
Scanning Electron Microscope (SEM) 
 
The plasmonic papers were examined using FEI-Quanta 450 SEM operating at 20 kV to 
produced visual images of the papers. Prior to this analysis, the papers were coated with a thin 
gold film using a Denton vacuum sputter coater (DESK II), to avoid common charging problems. 
The images were collected to measure the general size distribution of plasmonic particles and to 
visualize overall packing patterns of the NPs on the surface of the filter paper. 
 
 
Surface Enhanced Raman Spectroscopy (SERS). 
 
To evaluate SERS response of the vertical flow assay, SERS spectra were collected using 
an Enwave Optronics, Inc. ProRaman-L-785B instrument configured with a 785 nm excitation 
source set to 10 mW at the sample surface and a high-sensitivity CCD thermoelectrically cooled 
to -60 °C. The sample was placed on an x-y-z sample stage and the laser was focused on the 
substrate surface by maximizing the SERS intensity. After focusing the sample, the stage was 
automated to move linearly along the x-direction during the 10 sec spectral acquisition as a 
means of increasing the sampling area on the capture substrate, effectively averaging signal from 
different locations on the substrate [104]. Five spectra were collected from each sample substrate 
24  
and baseline corrected using the auto-baselin-2 algorithm built into the Enwave application 
software (ProRaman Reader V8.2.8). 
 
 
Dynamic Light Scattering (DLS) 
 
The adsorption of the antibodies on the AuNPs of the ERL were confirmed by measuring 
the mean hydrodynamic diameter and polydispersity of the AuNPs before and after the 
preparation of the ERLs with a Malvern Zetasizer Nano ZSP. Unconjugated AuNP and 
synthesized ERLS were diluted 2-fold with nano pure water and placed in a micro-volume 
disposable Eppendorf cuvette for DLS analysis. The sample was equilibrated for 60 sec prior to 
analysis and each size measurement was determined from 10 runs, 10 sec each. 
UV-Visible Spectrometer 
 
The synthesized gold nanoparticles used to prepare the plasmonic paper were 
investigated to assess the number of AuNPs loaded on the filter paper by measuring the 
extinction of the AuNP suspension before and after adsorption onto the filter paper. The UV- 
visible instrument used for this analysis was Agilent 8453 spectrophotometer (Agilent 
Technologies, Santa Clara, CA). The instrument has a photodiode detector with a spectral range 
of 190 -1100 nm. Prior to sample analysis the instrument was blanked with 2 mM borate buffer 
(pH 8.5). The prepared plasmonic paper was also characterized using a surface UV-Vis-IR 
spectrophotometer (300 – 1700 nm) equipped with a reflectance probe (StellarNet). 
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CHAPTER III: RESULTS AND DISCUSSION 
 
Assay Design and Sensing Principle 
 
A general overview of the SERS-based vertical flow immunoassay is illustrated in Figure 
 
8. Central to this platform is AuNP-loaded plasmonic paper, which serves as a capture substrate 
for the detection of antigens. Antibody is pre-immobilized onto the plasmonic paper and antigen 
is extracted and concentrated on the substrate as the sample solution passes through to an 
absorbing pad via capillary action. In a second step, ERLs are spontaneously and vertically 
passed through the plasmonic paper to specifically label captured antigen and facilitate SERS- 
based detection. The micron-sized pores in the filter paper allow any excess nanometer-sized 
ERLs to rapidly and freely pass through the plasmonic paper to waste collected in the absorbent 
pad. The plasmonic paper provides two key features. First, antibody irreversibly adsorbs onto 
AuNPs embedded in the filter paper [105-108], to form a robust capture substrate that resists 
desorption and loss of function while solutions flow through the paper. Second, the AuNP 
embedded in the paper will form a sandwich-like structure with ERLs bound to captured antigen. 
This architecture greatly supports plasmonic coupling between the AuNPs to generate a large 
localized electric field between the sandwiched nanoparticles and significantly enhance the 
SERS signal relative to the isolated ERL in the absence of plasmonic coupling [98, 109-112]. In 
addition to the uniquely designed plasmonic paper to maximize analytical signal, the vertical 
flow format overcomes diffusional mass transport limitations of traditional immunoassays to 
substantially reduce assay time and does not suffer from the hook effect, as is the case for lateral 
flow assays, to improve quantitative capabilities [45]. 
A model antibody-antigen system was employed to establish proof-of-principle for the 
SERS-based LFA and illustrate the role of the plasmonic capture substrate. The plasmonic 
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capture substrate and ERLs were both synthesized with goat anti-mouse IgG polyclonal antibody 
and mouse IgG was employed as the antigen. The following sections detail the synthesis of the 
plasmonic paper, the role of the plasmonic paper to facilitate large SERS enhancements, and the 
assay parameters that impact analytical performance. After optimization, we defined the 
analytical figures of merit and applied the protocol to accurately quantify IgG in normal mouse 
serum. 
 
 
Figure 8. Illustration of the SERS-vertical flow immunoassay protocol. In the first step, the 
sample solution is vertically passed through the paper for antibody to extract the analyte. In the 
second step, ERLs are passed through paper to label the captured antigen. 
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Fabrication and Characterization of Plasmonic Paper 
 
Filter paper loaded with spherical AuNPs serve as the foundation of the capture substrate 
in the SERS-based vertical flow assay illustrated in Figure 8. Filter paper was selected because 
of its numerous advantages such as affordability, accessibility, biodegradability, disposability, 
modification, and variety of unique pore sizes. In this work, we selected Grade 4 and 40 
Whatman filter paper with nominal pore sizes of 25 µm and 8 µm, respectively. Figure 9 shows 
digital photographs of the two filter papers before and after loading with AuNPs, prepared by dip 
coating [97-100]. The change in color of the filter paper from white to purple indicates the 
adsorption of the AuNPs on the paper, and the consistent color across the full paper suggests 
uniform distribution on a macroscopic scale. SEM images confirm adsorption of the AuNPs onto 
the fibers of the filter paper with a mean diameter of 57.9 ± 12.5 nm. The images further reveal 
small aggregates consisting of a few AuNPs are formed on the filter paper during the dip coating 
process. Moreover, the SEM images show a greater loading density of AuNPs on the grade 4 
filter paper than the grade 40 filter paper. The AuNP adsorption efficiency was quantified by the 
changes of AuNP surface plasmon resonance (SPR) using UV-visible spectrophotometry. The 
AuNP suspension exhibited an extinction of 2.4 at 540 nm before filter paper was dipped into the 
suspension. After immersing the filter paper in the AuNP suspension for 24 h and subsequent 
removal, the remaining suspension displayed an extinction of 0.7 and 1.3 for the grade 4 and 40 
filter papers, respectively (Figure 9). These decreases in SPR bands represent the loading of 2.8 
× 1011 AuNPs and 1.8 × 1011 AuNPs on the grade 4 and 40 filter papers, respectively. 
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Figure 9. SEM images of plasmonic filter papers with their UV analysis of AuNPs solution of 
grade number 4 and 40 with their corresponding UV analysis of before and after loading on the 
papers. 
 
 
To support the detectably, different amounts of plasmonic AuNP loading onto these two 
papers, the surface UV-Vis-IR absorption patterns were obtained (Figure 10). Although 
obtaining surface absorption patterns by a reflectance probe is somewhat difficult due to the light 
absorbing characteristics of materials, the clearly different SPR patterns (i.e., broader SPR band 
at 545 nm and increased background peak over 700 nm) explained that the grade 4 filter paper 
possessed a relatively higher number of locally aggregated AuNPs than the grade 40 filter paper. 
The presence of slightly more and dense packing of AuNPs could induce a higher probability of 
effective plasmonic coupling that can favorably influence the degree of SERS enhancements. 
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Figure 10. Surface UV-Vis-IR spectra of AuNPs loaded onto plasmonic papers of grade number 
4 and 40 filter papers. 
 
 
Role of Plasmonic Paper 
 
SERS-based vertical and lateral flow immunoassays have been previously developed 
using paper and nitrocellulose membranes as capture substrates. The goal of this work is to 
capitalize on the benefit afforded by a plasmonic capture substrate to create sandwich-like 
structures and achieve greater signal enhancements. To establish the value of the plasmonic 
capture substrate, the vertical flow assay was performed using unmodified filter paper and 
plasmonic filter paper. Antibody was deposited on unmodified filter paper and AuNP-embedded 
filter paper to form the capture substrate [113, 114]. After blocking the paper with BSA, 100 µL 
of the positive control sample (100 ng/mL of mouse IgG) was passed through the capture 
substrate. The sample solution quickly passed through the unmodified filter paper and grade 4 
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plasmonic paper in less than 10 sec; however, the 100 µL sample required more than 2 min to 
flow through the grade 40 plasmonic paper. After allowing the sample to completely pass 
through the capture substrate to the absorbent pad, 100 µL of ERLs were precisely applied to the 
sample and allowed to pass through the capture substrate to label the antigen extracted by the 
capture substrate. Again, the ERL flow rate was significantly faster through the grade 4 
plasmonic paper than the grade 40 plasmonic paper. After rinsing the paper with PBS (100 µL), 
SERS spectra were collected to quantify the bound antigen. Representative SERS spectra are 
presented for each of the capture substrates in Figure 11. As is evident, the SERS signal is 
characteristic of the Raman reporter molecule, 4-NBT, used to synthesize the ERLs, and include 
prominent bands at 1338 cm-1 (symmetric NO2 stretch), 1559 cm-1 (C=C), 1153 cm-1 (C-O), and 
850 cm-1 (C-H) [115, 116]. Importantly, the signal is markedly increased for the plasmonic paper 
capture substrates relative to the capture substrate prepared with unmodified filter paper (Figure 
11). Plasmonic paper resulted in ~4-fold and ~10-fold increase in signal for the capture substrate 
prepared with grade 40 and grade 4 filter paper, respectively, relative to the unmodified paper. 
Negative control samples were also analyzed to confirm that the signals obtained for the 
mouse IgG sample was due to specific antibody-antigen interactions rather than non-specific 
binding of the ERLs (e.g., physical adsorption) in the filter paper used as the foundation of the 
capture substrate. To this end, PBS was passed through the capture substrates in the first step. 
Subsequently, ERLs were passed through the capture substrates and analyzed via SERS (Figure 
11). The signal measured for the PBS negative control was substantially lower than that observed 
for the analysis of the positive control sample for each of the capture substrates. These results 
confirm the specificity of antibody-antigen interaction yet reveal some non-specific binding of 
the ERLs. 
31  
Collectively, these results clearly demonstrate greater SERS signals are obtained for the 
plasmonic capture substrates than the unmodified capture substrate. Interestingly, the plasmonic 
paper fabricated with grade 4 filter paper provided greater signal for the analysis of the positive 
control and lower signal for the analysis of the negative control sample than the grade 40 filter 
paper. As indicated earlier, the SERS enhancement is as a result of interparticle coupling that 
generates strong localized electromagnetic fields to maximize SERS signal from the substrate. 
Our results suggest that SERS enhancement provided by the plasmonic capture substrate 
corresponds to the number of plasmonic nanoparticles that are present on the surface of the 
paper. Moreover, the paper with the bigger pore size, e.g., grade 4, resulted in less non-specific 
binding of ERLs to generate less false-positive signal. Owing to this dual benefit, Whatman filter 
paper grade number 4 was selected to prepare plasmonic capture substrates and optimize the 
assay parameters. 
Figure 11. SERS spectra collected using bare filter paper, plasmonic filter papers of grade 4 
filter paper, and grade 40 plasmonic filter paper as the capture substrate in a SERS-RVF 
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immunoassay. The positive control samples represent the analysis of 100 ng/mL mouse IgG and 
the negative control samples represent the analysis of PBS. 
 
 
Optimization of Assay Protocol 
 
The following section explains the studies of the various assay parameters that enabled 
achievement of the optimized conditions which focus on varying the amount of capture 
antibodies, volume of ERLs and rinsing volume of PBS. 
 
 
Amount of Capture Antibody 
 
The ability to capture and concentrate antigen on the surface of the plasmonic paper as it 
passes through correlates with the number of capture antibodies available on the substrate. 
Therefore, the amount of the antibody deposited on the surface of the paper is an important 
parameter that can contribute to the analytical performance of the vertical flow immunoassay. 
Ideally, sufficient antibody is added to the plasmonic paper to saturate all available 
immobilization sites. However, addition of a large excess of antibody must be avoided to 
minimize the cost of the assay. To this end, goat anti-mouse IgG antibody (1 to 4 μg) was 
deposited on plasmonic paper (grade 4) to prepare capture substrates with variable amounts of 
capture antibody. A positive control sample (100 ng/mL antigen) and negative control sample 
(PBS) were analyzed with each capture substrate, using 100 µL of ERLs and 100 µL of PBS for 
subsequent labeling and rinsing, respectively. The SERS signal as a function of the amount of 
capture antibody is plotted for the positive and negative samples in Figure 12a. The positive 
control signal increased as the amount of deposited capture antibody increased from 1 to 2 µg; 
however, no further increase was observed for the positive control sample with the deposition of 
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more than 2 µg of capture antibody. The signal for the negative control sample was independent 
of the mass of capture antibody immobilized on the capture substrate. Based on the results of this 
experiment, 2 μg of capture antibody was selected for cost effectiveness, since this mass 
provided enough antibodies to effectively maximize the capture of antigen in a 100 ng/mL 
sample and produce a maximum SERS signal. 
To understand the activity of these capture antibodies, a paper to paper variability 
analysis was conducted which are shown in Figures 12b and 12c. Each bar represents average 
intensity of five SERS spectra collected from five different location on the paper with error bars. 
The results of the two papers show the same trend with statistically equivalent SERS intensities. 
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Figure 12. Effect of the amount of capture antibody on plasmonic filter paper grade number 
 
4. obtained by varying the mass of the capture antibody to capture 100 ng/mL mouse IgG, 
with subsequent labelling and rinsing using 100 μL of ERLs and 100 μL of PBS. (a) positive 
and negative control samples (b) plasmonic paper 1 (c) plasmonic paper 2. 
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Volume of Extrinsic Raman Labels (ERLs) 
 
The effect of ERL volume on SERS intensity was investigated to maximize the analytical 
signal by ensuring all the captured antigen was labelled. Plasmonic paper was loaded with 2 µg 
of capture antibody to prepare the capture substrate. A positive control sample (100 ng/mL 
antigen) or a negative control sample (PBS) was passed through the capture substrate followed 
by varying volumes of ERLs (25, 50, 100, and 200 µL) to label the capture antigens. After 
rinsing with 100 µL of buffer SERS spectra were collected, and the average intensities are 
plotted as a function of ERL volume in Figure 13a. The SERS signal increases as the ERL 
volume increases from 25 to 100 µL, suggesting that <100 µL of ERLs is insufficient to label all 
of the captured antigen for a sample concentration of 100 ng/mL. While there was a slight 
increase in the mean signal when the ERL volume increased from 100 to 200 µL the difference 
was not statistically different at the 95% confidence level; thus, indicating that 100 mL of ERLs 
was sufficient to label all antigens captured on the substrate for the 100 ng/mL sample. It is 
worth noting that analysis of samples with a concentration greater than 100 ng/mL may result in 
more captured antigens and therefore require a greater ERL volume to fully label all antigen 
molecules. Importantly, the signal of the negative control samples did not statistically differ 
among any of the ERL volumes tested. Therefore, based on the parameters used in this 
optimization study, 200 µL of ERLs were considered optimized and used for subsequent assays. 
To understand the activity of the ERL, a paper to paper variability analysis were 
conducted which are shown in Figure 13b and 13c. Each bar represents average intensity of five 
SERS spectra collected from five different location on the paper with error bars. The results of 
the two papers shows the same trend with statistically equivalent SERS intensities. 
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Figure 13. Effect of ERL volume on SERS intensity of plasmonic papers grade number 4 
capture substrate. Obtained using 2 μL of 1mg/ml anti-goat mouse IgG, 100 ng/ml of mouse 
IgG and 50 μL of PBS rinsing volume with variable ERL volumes. (a) positive and negative 
control samples (b) Paper 1 (c) Paper 2. 
 
 
Volume of Rinsing Buffer 
 
We investigated the effect of rinsing volume in an effort to minimize non-specific 
binding. In this study, positive (100 ng/mL antigen) and negative (PBS) were analyzed by the 
vertical flow assay using the optimized mass of capture antibody (2 μg) and volume of ERLs 
(200 μL). Following the labeling step, different volumes of the rinsing buffer were applied to the 
sample well and passed through the capture substrate to remove non-specifically bound ERLs. 
Figure 14a plots the SERS intensities for the negative samples as a function of rinse buffer 
volume. The signal for the negative control sample is a measure of the non-specific binding, and 
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the data show that the negative control signal decreases as the volume of rinse buffer increases 
from 50 to 200 μL. That data clearly shows that excess unbound ERLs remain in the capture 
substrate filter paper when the rinse volume was less than 200 μL. An increase to 400 μL of PBS 
rinsing buffer did not lead to a further reduction in the background signal. Figure 14a (inset) 
plots the signal collected for the positive control samples as a function of PBS rinsing volume. 
The data show a decrease in the signal for the positive control sample as the rinse volume 
increases from 50 to 100 µL, which is likely due to the removal of excess unbound ERLs. The 
positive control signal is independent of rinse volumes between 100 and 400 µL, which suggests 
that these volumes do not disrupt the specific antibody-antigen interactions. Based on the 
assessment of these results, we selected 300 µL of rinsing volume for subsequent optimized 
assays. This volume of rinsing buffer ensures a thorough removal of excess, non-specifically 
bound ERLs and maintains the maximum analytical signal, while balancing the assay time. 
Larger volumes require more time for the buffer to pass through the capture substrate, and it is 
noteworthy that the flow rate decreases as the absorbent pad becomes saturated with liquid. 
To understand the activity of the rinsing buffer, a second sample was analyzed using 
different prepared plasmonic paper with same rinsing volume variation and the same conditions 
and the results are plotted in Figure 14b. Each bar represents the average intensity of five SERS 
spectra collected from five different locations on the paper with error bars. 
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Figure 14. Effect of PBS rinsing volume on SERS intensity of capture substrate. Obtained 
using 2 μL of 1 mg/mL anti-goat mouse IgG, 100 ng/mL of mouse IgG, 200 μL ERL volumes 
with variable PBS rinsing volume. (a) SERS intensity as a function of rinsing buffer (b) 
Average SERS intensity as a function of rinsing buffer second experiment. 
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Analytical Performance – Dynamic Range, Detection Limit, Reproducibility, 
 
Selectivity 
 
The analytical performance of the assay was evaluated using the optimized conditions to 
generate a calibration curve for the analysis of mouse IgG and establish the dynamic range, 
detection limit, and reproducibility. Three assays for mouse IgG were performed on three 
different weeks using three independently prepared suspensions of ERLs and three 
independently prepared sets of plasmonic paper. Raman spectra illustrating the positive and 
negative controls are shown in Figure 15. 
 
 
Figure 15. Illustration of SERS spectra of positive and negative control samples. 
 
 
A calibration curve was generated for each independent assay to allow for analysis of 
intra- and inter-assay reproducibility. Concentration-dependent SERS spectra are presented in 
Figure 16 for one calibration dataset. 
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Figure 16. SERS spectra of concentration dependent assay. Obtained using optimized 
conditions and varying the concentration of the mouse IgG in ng/mL. 
 
 
As is evident, the SERS intensity increases with a corresponding increase in antigen 
concentration. The most intense band at 1338 cm-1, due to the symmetric nitro stretch, is plotted 
as a function of antigen concentration to generate a calibration curve (Figure 17). Each data point 
represents the average signal collected from five different locations across the capture substrate 
and the error bars represent the standard deviation. The spot-to-spot variation in analytical signal 
measured 10-20% for most samples, although at low concentrations, e.g., 0.5 ng/mL, where the 
signal was small, it varied as much as 37%. 
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Figure 17. Calibration curve of the VFA obtained using the optimized conditions with limit of 
detection. 
 
 
Calibration plots for two additional independent assays (assay 2 and assay 3) are 
presented in Figure 18. Critical analysis of the raw signals to evaluate the inter-assay reveals that 
the percent relative standard deviations (%RSD) are 10-30% for a given concentration. Closer 
inspection of the calibration plots shows that each dataset has a similar plot, in which the signal 
increases for sample concentrations between 0 and 100 ng/mL before reaching a maximum 
signal as the capture substrate becomes saturated at concentrations greater than 100 ng/mL. Each 
of the three independent assays shows a slightly different maximum signal at saturation. While 
the dynamic range and overall curve shape, i.e., biding behavior, is similar for each assay, the 
differences in maximum signal are attributed to differences in the synthesized plasmonic paper 
43  
substrates responsible for the SERS enhancement. To support this claim, we recently found 
 
~20% variability in SERS signals collected from plasmonic papers [98]. 
 
 
To account for the differences in plasmonic paper enhancement, each calibration curve 
was normalized with respect to its maximum signal (Figure 19). After normalization to account 
for substrate differences the inter-assay variability was significantly reduced to ~10-20%. 
 
 
 
Figure 18. Calibration plots for absolute averaged intensity of three independent assays. 
Obtained by plotting absolute average intensity as a function of concentration of mouse IgG in 
ng/mL using the optimized condition. 
44  
 
 
 
 
 
Figure 19. Calibration plots for normalized averaged intensity of three independent assays. 
Obtained by plotting normalized intensity as a function of concentration of mouse IgG in 
ng/mL using the optimized condition. 
 
 
The detection limit of the SERS vertical flow assay was defined as the antigen 
concentration that produces a signal equal to the blank signal plus three times the standard 
deviation of the blank measurement. The calibration data presented in Figure 17 was best fit to a 
ligand binding model, i.e., saturation curve (Equation 1) [117], 
                                           𝑦𝑦 =  𝐵𝐵𝑚𝑚𝑚𝑚𝑚𝑚𝑥𝑥
𝐾𝐾𝑑𝑑+𝑥𝑥
                       (1) 
 
 
where Bmax represents the maximum binding, i.e., maximum signal, and Kd is the 
antibody-antigen dissociation constant. Based on the best fit of the data, and replicated signals 
acquired for the blank, the detection limit was 3 ng/mL. Similar evaluation of the two additional 
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independent calibration datasets presented in Figure 18 resulted in detection limits of 8 and 3 
ng/mL. This detection limit is equivalent to that obtained for a solution based assay we 
previously reported using a similar antibody-antigen system, yet this current platform does not 
suffer from the hook effect [102]. Moreover, a filter based immunoassay using a syringe to 
facilitate flow rather than a vertical flow-based absorbent pad yielded a detection limit of 1-10 
ng/mL for mouse IgG, but required 1 mL of sample and 10 minutes to complete the assay rather 
than the 100 µL of sample and ~2 min assay time required for this current format [118]. It is 
worth noting that other vertical flow assays without a plasmonic capture substrate have reported 
lower detection limits than we present here [101, 119, 120]; however, those works employed 
monoclonal antibodies, and it is well-established that the binding affinity of the antibody-antigen 
governs the detection limit; thus, we can only compare to other studies that used goat anti-mouse 
IgG polyclonal antibodies as a model system. 
In an effort to determine the effect of sample matrix on the assay performance, 
calibration standard solutions of mouse IgG antigen were prepared in PBS and in 10% rabbit 
serum. The calibration curves generated with each of these solvents are overlaid in Figure 20. 
Similar calibration curves are obtained for each of these sample matrices and provide two key 
findings. First, these results confirm that the assay can capture the antigen protein in the presence 
of a complex biological matrix. Second, this experiment validates the specificity of the 
immunoassay given that rabbit serum contains a large concentration of rabbit IgG which is not 
detected by the anti-mouse IgG capture substrate and ERLs. 
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Figure 20. Calibration plots of mouse IgG prepared in PBS and 10% rabbit serum. 
 
 
 
Application of the SERS-VFA to the Analysis of Mouse Serum 
 
Based on these encouraging results, we then applied our SERS-VFA to determine the 
concentration of mouse IgG in mouse serum. IgG is an abundant protein found in serum and has 
normal concentration range of 5-13 mg/mL in serum collected from healthy mice. Given that the 
concentration of mouse IgG in normal serum is outside of the limit of linearity (Figure 17) for 
the SERS-VFA, the mouse serum was diluted 1:106 using PBS as a diluent. We prepared three 
independent mouse serum samples (unknown A, B and C, Table 2) and the diluted serum 
samples were analyzed using a newly prepared set of plasmonic paper capture substrates. 
Concurrently, the capture substrates were used to analyze mouse IgG standards to generate a 
calibration curve. (Table 1 and Figure 16). The IgG concentration in the diluted serum measured 
11 ± 3 ng/mL, based on the best fit of the calibration data to the ligand binding curve, which 
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translates to an IgG concentration of 11 ± 3 mg/mL in the original undiluted mouse serum 
sample. This experimental IgG concentration in normal mouse serum is in the expected range 
and is consistent with measured values for mouse IgG in normal serum. 
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Figure 21. Calibration curve to determine IgG in mouse serum obtained using optimized 
condition. 
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Figure 22. Limit of linearity of the calibration curve. 
 
 
Table 1. Mouse IgG (mIgG) Diluted in PBS. 
 
mIgG (ng/mL)  Mean SERS 
Intensity (cts) 
0 455 ± 99 
0.1 475 ± 94 
0.5 550. ± 49 
1 655 ± 92 
10 1194 ± 118 
50 3163 ± 241 
100 6138 ± 304 
200 6417 ± 532 
400 7164 ± 468 
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Table 2. Average SERS intensity of diluted mouse serum. 
 
 
Unknown 
  (ng/mL)  
Averaged 
SERS intensity  
A 577 ± 62 
B 683 ± 89 
C 1660 ± 98 
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CHAPTER IV: CONCLUSION AND FUTURE WORKS 
 
Research Summary 
 
Over the past decades, the point-of-care diagnostic platform has become an integral part 
of medicine and environmental analysis due to the benefit of instant results. The current POCT 
that has obtained commercial success is the LFA. Despites the many advantages of these 
techniques, they also have limitations. Latera flow devices can produce instant results; however, 
they cannot be applied for an accurate quantification analysis. Moreover, LFAs suffer from a 
high rate of false negative results. These challenges result in inaccurate results and therefore 
limits its full potential in biomedical applications. 
Gold nanoparticle-protein conjugation has become an active area of research due to the 
selective nature of antibody-based assays, biocompatibility and excellent optical properties of 
gold nanoparticles. There are many existing methods demonstrating various ways of 
immobilizing proteins on gold nanoparticles with the majority of them focused on the electronic 
and covalent interaction between the gold nanoparticle and proteins. Many point-of-care 
techniques take advantage of these to improve the current methods of detection. One area that 
has gained much attention is surface enhanced Raman spectroscopy (SERS) due to its unparallel 
sensitivity for single molecule detection. Recently, SERS-based immunoassays have become an 
active area of research and many researchers are coupling SERS with the current methods (e.g 
LFA) to improve sensitivity, quantification and analysis time. 
In this work, we developed a SERS-based rapid vertical flow assay employing plasmonic 
paper as the capture substrate. Using mouse IgG as a model antigen, we established a novel 
strategy to promote a significant signal enhancement for SERS detection by AuNP-embedded 
filter paper compared to previously utilized paper-based substrates. Our approach takes 
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advantage of the plasmonic coupling between the underlying plasmonic capture substrate paper 
and the nanoparticle labels, e.g., ERLs, to generate exceedingly large signals. Moreover, the 
vertical flow format enables the capture and concentration of analyte from a small volume of 
sample for rapid detection using capillary action to actively transport the sample through the 
capture substrate to overcome diffusion limited mass transport. Lastly, the vertical flow approach 
is not complicated by the hook effect for the analysis of highly concentrated samples. The ease 
of use, speed of analysis, low detection limits, and low cost of components suggest this assay is 
poised to meet the demands of point-of-care diagnostic testing, on-site environmental analysis, 
and point-of-need biodefense applications. 
The summary of the results obtained during this study are briefly explained according to 
the following sections: 
Section A: Optimized assay parameters 
 
Section B: Analytical performance of the SERS-VFA 
 
Section C: Application of the SERS vertical flow assay for determination of IgG 
concentration in mouse serum. 
 
 
Section A: Optimization of Assay Parameters 
 
Development of assay protocols for an accurate and reliable testing platform requires an 
optimized system that is reproducible. The first part of this research was to obtain an optimized 
system that enabled maximum performance of the assay. The parameters we investigated in this 
analysis were the effect of antibody on the capture substrate, the effect of ERL volume and the 
volume of the rinsing buffer. The quantities of these parameters have a significant impact on the 
assay results and therefore must be carefully controlled. 
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As an initial step, we first optimized the amount of antibodies deposited on the plasmonic 
paper. The antibodies were strategically immobilized on the plasmonic papers to control the 
binding sites; this determined how much antibody was available on the plasmonic paper to 
capture the antigen upon passing the sample through the paper in order to bind to the ERL. We 
determined that the SERS signal response is dependent on the number of antibodies available on 
the surface of the paper to antigen molecules. As the number of antibodies increased the SERS 
signal intensity increased due to the higher number of antigens that were captured until excess 
antibodies were available to bound all antigen molecules. 
The effect of ERL volume on SERS intensity was investigated to determine if the amount 
of binding, e.g ERL-antigen complex was mass dependent. The quantity of the ERLs available 
on the surface of the membrane determines the intensity of the SERS signal which was used to 
quantify amount of antigen captured from the flowing sample. Again, we determined that the 
volume of the ERL was directly proportional to the SERS signal intensity and that surface 
saturation occurs at the maximum volume where all captured antigens have become bound with 
the ERL. 
The nonspecific bindings of ERL can result to false positive results and therefore must be 
minimized. This was done using PBS rinsing buffer that contains surfactants. We concluded that 
as the rinsing volume increases the negative control signal decreases however excess volume can 
marginalized the assay results and therefore must be controlled. 
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Section B: Analytical Performance of the SERS-VFA 
 
The second part of this thesis was to demonstrate the capability of our developed SERS- 
based vertical flow assay by determining the dynamic range, limit of detection, selectivity and 
reproducibility. A calibration curve was generated, and the dynamic range was established 
between 1 -100 ng/mL, while saturation occurs at greater antigen concentrations. The spot-to- 
spot variation of the paper was found to be ~ 10-20% which is comparable to available evidence 
of SERS signal collected from plasmonic paper. The calibration curve was fitted to a ligand 
binding curve and determined the limit of detection to be 3 ng/mL which is equivalent to a 
solution-based assay we previously developed using the same antigen-antibody system. In 
addition, our developed system uses minimal sample volume of 100 µL and less time of 2 mins 
which is better than our previous methods which require 1 mL of sample solution and 10 mins 
for analysis. We were able to establish the selectivity of our system by generating a calibration 
curve using mouse IgG prepared in 10% rabbit serum which is similar to that prepared in the 
PBS. 
 
 
Section C: Application of the SERS-VFA to Determine IgG in Mouse Serum 
 
Our vertical flow assay was used to investigate the concentration of mouse IgG in normal 
mouse serum to evaluate the quantitative capability of the technique. The mouse serum which 
has high concentration of mouse IgG (5 -13 mg/mL) falls outside the limit of linearity of our 
SERS VFA. By a million times dilution of the serum followed by SERS analysis the amount of 
mouse IgG present in the serum was accurately determined. 
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Future Works 
 
One avenue of future work will include extending our current SERS-based detection 
strategy to applications involving simultaneous multiplexed detection. The use of ERLs prepared 
using different antibodies and Raman labels allowed simultaneous detection of different 
biomarkers by first immobilizing two different types of capture antibodies on the plasmonic 
paper. A sample with the potential to contain two antigens would then pass through the 
plasmonic capture substrate and each antigen would be extracted by its respective antibody. The 
mixed ERLS would then be used to label captured antigens. The unique SERS spectra of each 
Raman label would then be used to identify the presence and quantity of each antigen 
independently. 
A second avenue worthy of exploration is the plasmonic system. In this SERS RVF 
assay, spherical gold nanoparticles are embedded in the paper substrate and spherical gold serves 
as the core of the ERL. We have recently shown that sandwiched structures of different 
plasmonic nanoparticles can lead to better plasmonic coupling and SERS enhancement than the 
AuNP-AuNP system used to develop this assay. In this work miRNA was sandwiched between a 
silver nanoparticle and anisotropic gold nanoparticle. As is evident in ref [61], SERS response of 
the miRNA sandwiched between a silver nanoparticle and anisotropic gold nanoparticle was 
substantially greater than miRNA sandwiched between two spherical AuNPs. These results 
suggest our plasmonic capture substrate should be prepared with anisotropic gold particles and 
the ERLs should consist of a silver nanoparticle core for even greater enhancement. In addition, 
exploring different plasmonic particles, we also plan to apply a third layer of these different 
types of nanostructures to potentially increase the sensitivity of the SERS-VFA. In our 
preliminary work we analyzed samples by applying a third layer of concave cube solution of 
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AuNP to a sandwiched mouse IgG between two spherical AuNPs. The SERS response in the 
third layer analysis shows greater enhancement than that between the sandwiched system as 
evidenced in Figure 18. This result also demonstrates the capability of the concave cube gold 
nanoparticle to be used as ERL and plasmonic paper to increase the sensitivity of the SERS- 
VFA. 
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Figure 23. SERS spectra of concave cube AuNPs solution 3rd layer analysis of mouse IgG. 
Obtained using 10 µg/ml mouse IgG with the optimized conditions of the SERS–VFA. 
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